Literature DB >> 10576590

Existence of a bioactive lipid, cyclic phosphatidic acid, bound to human serum albumin.

T Kobayashi1, R Tanaka-Ishii, R Taguchi, H Ikezawa, K Murakami-Murofushi.   

Abstract

A novel bioactive lipid, cyclic phosphatidic acid (cPA), was identified in lipids bound to human serum albumin. A cPA fraction was extracted and purified from human serum albumin by use of a combination of preparative TLC and HPLC. Electrospray ionization mass spectrometry of the purified fraction showed molecular ions corresponding to cPA, which was composed of some different fatty acid species. The most abundant component was identified as palmitoyl-cPA by tandem mass spectrometry using collision-induced dissociation. These data have established that cPA is a naturally occurring lipid bound to human serum albumin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576590     DOI: 10.1016/s0024-3205(99)00483-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.

Authors:  Daniel L Baker; Yuko Fujiwara; Kathryn R Pigg; Ryoko Tsukahara; Susumu Kobayashi; Hiromu Murofushi; Ayako Uchiyama; Kimiko Murakami-Murofushi; Eunjin Koh; Russell W Bandle; Hoe-Sup Byun; Robert Bittman; Dominic Fan; Mandi Murph; Gordon B Mills; Gabor Tigyi
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

2.  Age-related changes in cyclic phosphatidic acid-induced hyaluronic acid synthesis in human fibroblasts.

Authors:  Katsura Sano; Mari Gotoh; Kyoko Dodo; Noriaki Tajima; Yoshibumi Shimizu; Kimiko Murakami-Murofushi
Journal:  Hum Cell       Date:  2017-10-23       Impact factor: 4.174

3.  Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid.

Authors:  Ayako Uchiyama; Mutsuko Mukai; Yuko Fujiwara; Susumu Kobayashi; Nobuyuki Kawai; Hiromu Murofushi; Masahiro Inoue; Shigenori Enoki; Yuichiro Tanaka; Tamotsu Niki; Tetsuyuki Kobayashi; Gabor Tigyi; Kimiko Murakami-Murofushi
Journal:  Biochim Biophys Acta       Date:  2006-10-14

4.  Urinary metabolomic profiling in rats exposed to dietary di(2-ethylhexyl) phthalate (DEHP) using ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC/Q-TOF-MS).

Authors:  Xinwen Dong; Yunbo Zhang; Jin Dong; Yue Zhao; Jipeng Guo; Zhanju Wang; Mingqi Liu; Xiaolin Na; Cheng Wang
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-30       Impact factor: 4.223

Review 5.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 6.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs.

Authors:  Sara L Morales-Lázaro; Barbara Serrano-Flores; Itzel Llorente; Enrique Hernández-García; Ricardo González-Ramírez; Souvik Banerjee; Duane Miller; Veeresh Gududuru; James Fells; Derek Norman; Gabor Tigyi; Diana Escalante-Alcalde; Tamara Rosenbaum
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

Review 8.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 9.  Cyclic phosphatidic acid - a unique bioactive phospholipid.

Authors:  Yuko Fujiwara
Journal:  Biochim Biophys Acta       Date:  2008-05-23

10.  Protection of neuroblastoma Neuro2A cells from hypoxia-induced apoptosis by cyclic phosphatidic acid (cPA).

Authors:  Mari Gotoh; Katsura Sano-Maeda; Hiromu Murofushi; Kimiko Murakami-Murofushi
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.